Page last updated: 2024-10-26

ellipticine and Carcinoma, Neuroendocrine

ellipticine has been researched along with Carcinoma, Neuroendocrine in 1 studies

ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.

Carcinoma, Neuroendocrine: A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round blue cells, granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small (oat) cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumarasamy, VM1
Sun, D1

Other Studies

1 other study available for ellipticine and Carcinoma, Neuroendocrine

ArticleYear
Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.
    International journal of oncology, 2017, Volume: 51, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carbazoles; Carcinoma, Neuroendocrine;

2017